AMW

AMW GmbH is a specialty pharmaceutical company focused on biodegradable implants, providing patients and partners access to value-added medicines for improved adherence and cost-effective therapies. The Company covers the entire value chain, from (co-)development to manufacturing and international commercialization. AMW has two approved medical products, implants releasing goserelin and leuprorelin, which are distributed worldwide through both local and global pharma partners.